Surgery Partners, Inc. (SGRY)

Surgery Partners, Inc. (SGRY) is a healthcare company (medical care facilities) based in the United States. The share price is $26.78, down 0.06% on the day, which values the company at $3.5B. Price as of 17 Nov 2026, 19:11 UTC, from Yahoo Finance.

Key facts

Share price
$26.78−0.06% today
Market value
$3.5B
Forward P/E
133.8×
Funk Score
37/100
Against its own history
Well above its usual priceusual price $20.29
200-week average
$24.927% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Surgery Partners, Inc. in more detail

SGRY trades at 133.8× next year's expected earnings, 1.0× sales. Measured against its own history, the price is 32% above what its usual multiples would imply ($20.29) — well above its usual price. It sits 7% above its 200-week average of $24.92.

Over the last five fiscal years Surgery Partners, Inc. has compounded revenue 12.2% a year, free cash flow -0.8% a year. Its Funk Score is 37 out of 100 (financial strength 1.3, profitability 3.5, growth 5.7, value 4.5, each out of 10).

In its favour: Five straight years of revenue growth. Worth checking: Altman Z in the distress zone; Share count keeps rising.

1 of the superinvestors tracked here hold SGRY, including Howard Marks (0.3% of the portfolio).

Superinvestors holding SGRY

1 of the investors tracked here report a position in their latest 13F filing.

Surgery Partners, Inc. (SGRY): questions and answers

What is Surgery Partners, Inc.'s market cap?

Surgery Partners, Inc. is valued at $3.5B at a share price of $26.78.

Is SGRY overvalued or undervalued?

Against its own history, SGRY is well above its usual price: the price is 32% above the $20.29 implied by the median multiples it has traded at (price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is SGRY above its 200-week moving average?

Yes. SGRY is 7.5% above its 200-week average of $24.92. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Surgery Partners, Inc. growing?

Over the last five fiscal years Surgery Partners, Inc.'s revenue grew 12.2% a year; over ten years revenue grew 13.2% a year.

Does SGRY pay a dividend?

Surgery Partners, Inc. does not currently pay a regular dividend.

Which famous investors own SGRY?

In their latest quarterly filings, Howard Marks (0.3% of the portfolio) hold SGRY. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Surgery Partners, Inc. (SGRY) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/SGRY

Underlying data: Yahoo Finance; company filings with the SEC.